STOCK TITAN

Freightos Ltd (CRGO) CSO sells 1,760 shares to cover RSU tax liabilities

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freightos Ltd Chief Strategy Officer Ian Arroyo reported selling a total of 1,760 ordinary shares on July 16, 2026 at $1.2700 per share in open-market or private transactions to cover tax liabilities from vested RSUs. He continues to hold RSU-derived shares and multiple stock option awards over Freightos ordinary shares.

Positive

  • None.

Negative

  • None.
Insider Arroyo Ian
Role Chief Strategy Officer
Sold 1,760 shs ($2K)
Type Security Shares Price Value
Sale Ordinary Shares F1, F2 760 $1.27 $965.20
Sale Ordinary Shares F1, F3 1,000 $1.27 $1K
holding Stock Option (right to buy) F4 -- -- --
holding Stock Option (right to buy) F4 -- -- --
holding Stock Option (right to buy) F4 -- -- --
holding Ordinary Shares F4 -- -- --
holding Ordinary Shares F4, F5 -- -- --
holding Ordinary Shares F4, F6 -- -- --
holding Ordinary Shares F4, F7 -- -- --
holding Ordinary Shares F4, F8 -- -- --
holding Ordinary Shares F4, F9 -- -- --
holding Ordinary Shares F4, F10 -- -- --
Holdings After Transaction: Ordinary Shares — 280,136 shares (Direct); Stock Option (right to buy) — 290,461 shares (Direct)
Footnotes (10)
  1. F1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
  2. F2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 7,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs have vested in full as of July 15, 2026 (reduced by any RSUs for which underlying shares have been sold to cover tax liability). In addition to the 760 shares sold as reported in this row and the 756 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 754 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 4,730 ordinary shares are currently held by the Reporting Person from the 7,000 RSUs originally granted.
  3. F3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 21,500 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs vest equally on a quarterly basis over seven calendar quarters (approximately 14.286% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by July 15, 2027. In addition to the 1,000 shares sold as reported in this row and the 995 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 992 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 18,513 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 21,500 RSUs originally granted.
  4. F4. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  5. F5. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
  6. F6. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that are now fully vested and have settled for underlying ordinary shares (as of July 15, 2026).
  7. F7. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 36,000 RSUs originally granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 1, 2028).
  8. F8. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
  9. F9. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.
  10. F10. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
Total shares sold 1,760 shares Aggregate ordinary shares sold on July 16, 2026 to cover RSU tax liability
Sale price per share $1.2700 per share Price for both ordinary share sale transactions on July 16, 2026
Remaining from 7,000 RSU grant 4,730 ordinary shares Currently held from 7,000 RSUs after multiple tax-related sales
Remaining from 21,500 RSU grant 18,513 RSUs and/or ordinary shares Currently held from 21,500 RSUs after tax-related sales
Option at $1.0700 49,473 underlying shares Ordinary shares underlying stock option expiring December 16, 2030
Option at $4.1700 (2031-07-19) 12,314 underlying shares Ordinary shares underlying stock option expiring July 19, 2031
Option at $4.1700 (2032-02-17) 228,674 underlying shares Ordinary shares underlying stock option expiring February 17, 2032
restricted share units ("RSUs") financial
"underlying 7,000 RSUs originally granted by the Issuer"
Section 16 regulatory
"before the Reporting Person was subject to Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
vesting commencement date financial
"by the three-year anniversary of the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
ordinary shares financial
"The ordinary shares reported in this row consist of"
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Freightos (CRGO) report for Ian Arroyo?

Ian Arroyo reported selling 1,760 ordinary shares of Freightos on July 16, 2026 at $1.2700 per share. Footnotes state the sales were executed to cover tax liabilities arising from the vesting of restricted share units (RSUs) previously granted to him.

At what price were the CRGO shares sold in Ian Arroyo's July 16, 2026 trade?

The reported Freightos (CRGO) share sales were executed at $1.2700 per share. Two open-market or private sale transactions are disclosed: 760 ordinary shares and 1,000 ordinary shares, both dated July 16, 2026, according to the Form 4 data and related footnotes.

Were Ian Arroyo's CRGO share sales made under a Rule 10b5-1 trading plan?

The filing indicates the transactions were not made under a Rule 10b5-1 trading plan. The Rule 10b5-1 checkbox is unchecked, and the footnotes instead describe the sales as undertaken to cover tax liability from vesting restricted share units.

How many shares remain from Ian Arroyo's 7,000 and 21,500 RSU grants at Freightos (CRGO)?

From the 7,000 RSU grant, footnotes report 4,730 ordinary shares currently held. From the 21,500 RSU grant, they state 18,513 RSUs and/or underlying ordinary shares are currently held, after prior sales to cover associated tax liabilities.

What stock options does Ian Arroyo hold in Freightos (CRGO) according to this Form 4?

He holds options over 49,473 shares at $1.0700 expiring December 16, 2030, and options over 12,314 and 228,674 shares at $4.1700 expiring July 19, 2031 and February 17, 2032, respectively, all on Freightos ordinary shares.

Why were Ian Arroyo's Freightos (CRGO) shares sold, according to the Form 4 footnotes?

Footnote F1 explains the sales were executed on Ian Arroyo’s behalf to cover tax liability triggered by the vesting of RSUs granted by Freightos. Additional footnotes detail remaining shares and RSUs from the affected grants after these and prior tax-related sales.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Arroyo Ian

(Last)(First)(Middle)
C/O FREIGHTOS LIMITED, PLANTA 10,
AVDA. DIAGONAL, 211

(Street)
BARCELONA08018

(City)(State)(Zip)

SPAIN

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Strategy Officer
2a. Foreign Trading Symbol
[N/A]
3. Date of Earliest Transaction (Month/Day/Year)
07/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/16/2026S(1)760D$1.274,730(2)D
Ordinary Shares07/16/2026S(1)1,000D$1.2718,513(3)D
Ordinary Shares(4)23,924D
Ordinary Shares(4)37,500(5)D
Ordinary Shares(4)37,500(6)D
Ordinary Shares(4)32,099(7)D
Ordinary Shares(4)38,000(8)D
Ordinary Shares(4)38,000(9)D
Ordinary Shares(4)54,600(10)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)(4)$1.0712/01/202412/16/2030Ordinary Shares49,47349,473D
Stock Option (right to buy)(4)$4.1707/01/202507/19/2031Ordinary Shares12,31412,314D
Stock Option (right to buy)(4)$4.1701/01/202602/17/2032Ordinary Shares228,674228,674D
Explanation of Responses:
1. The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
2. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 7,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs have vested in full as of July 15, 2026 (reduced by any RSUs for which underlying shares have been sold to cover tax liability). In addition to the 760 shares sold as reported in this row and the 756 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 754 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 4,730 ordinary shares are currently held by the Reporting Person from the 7,000 RSUs originally granted.
3. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 21,500 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs vest equally on a quarterly basis over seven calendar quarters (approximately 14.286% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by July 15, 2027. In addition to the 1,000 shares sold as reported in this row and the 995 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 992 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 18,513 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 21,500 RSUs originally granted.
4. There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
5. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
6. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that are now fully vested and have settled for underlying ordinary shares (as of July 15, 2026).
7. The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 36,000 RSUs originally granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 1, 2028).
8. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
9. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.
10. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
Remarks:
Exhibit List: Exhibit 24.1 - Power of Attorney.
/s/ Max Sitnick, Attorney-in-fact07/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)